Pure Global

Medicine chamber spacer - ARTG 398333

Access comprehensive regulatory information for Medicine chamber spacer in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 398333 and sponsored by GlaxoSmithKline Australia Pty Ltd, manufactured by GlaxoSmithKline Trading Services Limited in Ireland. The device registration started on October 25, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIb
ARTG 398333
Class IIb
Medicine chamber spacer
ARTG ID: 398333
Good Name: GlaxoSmithKline Australia Pty Ltd - Medicine chamber spacer
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The Volumatic Spacer Device is a breath activated holding device designed to enable the use of the pressurised metered dose inhaler by a patient. A chamber for use with Seretide, Ventolin and Flixotide metered dose aerosol inhalers, designed to hold the spray before it is breathed in.

Device Classification
Risk Class
Class IIb
Product Type
Procedure Pack
ARTG Category
General
Registration Information
ARTG ID
398333
Start Date
October 25, 2022
Effective Date
October 25, 2022
Manufacturer
Country
Ireland
Address
12 Riverwalk Citywest Business Campus, Dublin 24, D24 YK11